Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperglycemia toxicity and gastric emptying in newly diagnosed type 2 diabetes
ChiCTR1800019791Phase 4Not yet recruiting
- Sponsor
- Nanjing First Hospital
- Start
- Jan 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of human insulin in type 2 diabetes mellitus (T2DM), sponsored by Nanjing First Hospital. Primary endpoint: Mean blood glucose. Planned start Jan 2019; status: not yet recruiting.
02
Drugs
human insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR1800019791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800019791.